Dennis Watson to RNA, Antisense
This is a "connection" page, showing publications Dennis Watson has written about RNA, Antisense.
Connection Strength
0.256
-
Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer. Mol Ther. 2006 Feb; 13(2):357-65.
Score: 0.062
-
CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability. Cancer Res. 2005 Jul 15; 65(14):6228-36.
Score: 0.061
-
CaSm antisense gene therapy: a novel approach for the treatment of pancreatic cancer. Anticancer Res. 2003 May-Jun; 23(3A):2007-13.
Score: 0.052
-
The cancer-associated Sm-like oncogene: a novel target for the gene therapy of pancreatic cancer. Surgery. 2000 Aug; 128(2):353-60.
Score: 0.043
-
ETS2 function is required to maintain the transformed state of human prostate cancer cells. Oncogene. 1998 Dec 03; 17(22):2883-8.
Score: 0.038